All MPs, cutting across party lines, sought to know from health ministry officials about the availability of medicines. Bharatiya Janata Party’s Anil Jain, a medical doctor himself, asked if steps were being taken to check expensive medicines that pharmaceutical lobbies are pushing in the market. Some MPs suggested names of cheaper generic alternatives, and asked the government why it doesn’t promote these medicines and encourage local manufacture.
The members suggested that the government put in place national, state and district level plans under the National
Disaster Management Act to handle the Covid-19 pandemic. They also suggested amending the Disaster Management Act, 2005, to include the pandemic.
Questions were also asked on the availability of a vaccine or a drug to cure Covid-19. The health ministry officials said work was afoot, but did not give any timelines.
The meeting lasted for nearly three hours.
Business Standard has always strived hard to provide up-to-date information and commentary on developments that are of interest to you and have wider political and economic implications for the country and the world. Your encouragement and constant feedback on how to improve our offering have only made our resolve and commitment to these ideals stronger. Even during these difficult times arising out of Covid-19, we continue to remain committed to keeping you informed and updated with credible news, authoritative views and incisive commentary on topical issues of relevance.
We, however, have a request.
As we battle the economic impact of the pandemic, we need your support even more, so that we can continue to offer you more quality content. Our subscription model has seen an encouraging response from many of you, who have subscribed to our online content. More subscription to our online content can only help us achieve the goals of offering you even better and more relevant content. We believe in free, fair and credible journalism. Your support through more subscriptions can help us practise the journalism to which we are committed.
Support quality journalism and subscribe to Business Standard.